GH Research PLC (GHRS)
NASDAQ: GHRS · Real-Time Price · USD
12.73
-0.10 (-0.78%)
At close: Jun 13, 2025, 4:00 PM
12.76
+0.03 (0.24%)
After-hours: Jun 13, 2025, 4:04 PM EDT
GH Research Market Cap
GH Research has a market cap or net worth of $791.48 million as of June 13, 2025. Its market cap has increased by 17.65% in one year.
Market Cap
791.48M
Enterprise Value
476.80M
1-Year Change
17.65%
Ranking
Category
Stock Price
$12.73
Market Cap Chart
Since the IPO on June 25, 2021, GH Research's market cap has decreased from $808.33M to $791.48M, a decrease of -2.09%. That is a compound annual growth rate of -0.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 13, 2025 | 791.48M | 117.32% |
| Dec 31, 2024 | 364.20M | 20.71% |
| Dec 29, 2023 | 301.72M | -40.33% |
| Dec 30, 2022 | 505.64M | -58.34% |
| Dec 31, 2021 | 1.21B | 50.14% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 725.92B |
| Johnson & Johnson | 373.57B |
| Novo Nordisk | 353.21B |
| AbbVie | 338.27B |
| UnitedHealth Group | 281.72B |
| Abbott Laboratories | 235.37B |
| Novartis AG | 231.84B |
| AstraZeneca | 229.07B |